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Individual S-acylated cysteines differentially 
contribute to H-Ras endomembrane trafficking 
and acylation/deacylation cycles
ABSTRACT S-acylation/deacylation cycles and vesicular transport are critical for an adequate 
subcellular distribution of S-acylated Ras proteins. H-Ras is dually acylated on cysteines 181 
and 184, but it is unknown how these residues individually contribute to H-Ras trafficking. In 
this study, we characterized the acylation and deacylation rates and membrane trafficking of 
monoacylated H-Ras mutants to analyze their contributions to H-Ras plasma membrane and 
endomembrane distribution. We demonstrated that dually acylated H-Ras interacts with acyl-
protein thioesterases (APTs) 1 and 2 at the plasma membrane. Moreover, single-acylation 
mutants of H-Ras differed not only in their subcellular distribution, where both proteins local-
ized to different extents at both the Golgi complex and plasma membrane, but also in their 
deacylation rates, which we showed to be due to different sensitivities to APT1 and APT2. 
Fluorescence photobleaching and photoactivation experiments also revealed that 1) although 
S-acylated, single-acylation mutants are incorporated with different efficiencies into Golgi 
complex to plasma membrane vesicular carriers, and 2) the different deacylation rates of 
single-acylated H-Ras influence differentially its overall exchange between different compart-
ments by nonvesicular transport. Taken together, our results show that individual S-acylation 
sites provide singular information about H-Ras subcellular distribution that is required for 
GTPase signaling.
INTRODUCTION
Ras family proteins are monomeric guanosine triphosphatases 
(GTPases) that couple extracellular signals to the intracellular effec-
tor pathways that control cell proliferation, differentiation, and sur-
vival (Wennerberg et al., 2005). Dysregulation of these cellular func-
tions is a hallmark of cancer, with activating mutations in Ras having 
been detected in ∼20–35% of all human cancers (Ahearn et al., 
2012).
There are four ubiquitous (although functionally nonredundant; 
Hancock, 2003; Eisenberg et al., 2013) Ras isoforms, namely H-Ras, 
N-Ras, K-Ras4A, and K-Ras4B. The source of this nonredundancy 
relies on the Ras C-terminus hypervariable region, which is <10% 
homologous between the different Ras isoforms and contributes dif-
ferentially to their membrane-binding properties. Within this region, 
all Ras isoforms have a CAAX sequence (in which C is a cysteine, A 
is an aliphatic amino acid, and X is any amino acid) at the C-terminus 
that directs the posttranslational modification by farnesylation and 
methylation. These modifications convert an otherwise globular hy-
drophilic protein to one that associates with the cytoplasmic leaflet 
of cellular membranes (Wright and Philips, 2006; Ahearn et al., 
2012). Depending on the Ras isoform, a second signal for the mem-
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181 and 184 provide unique information for spatial organization and 
trafficking of H-Ras, thereby influencing its steady-state subcellular 
distribution and capacity to activate downstream signaling.
RESULTS
H-Ras(C181S) and H-Ras(C184S) mutants are 
membrane associated, S-acylated, and able to engage 
Ras downstream signaling
To have a better understanding of how acylation/deacylation cycles 
on cysteines 181 and 184 contribute to the efficient subcellular dis-
tribution of H-Ras, we decided to characterize in detail the subcel-
lular localization and acylation/deacylation processes of wild-type 
(H-RasWT), H-Ras(C181S), and H-Ras(C184S) single-acylation mutants 
and compared them to non–S-acylatable H-Ras(C181S,C184S) by 
using live-cell imaging (Figure 1A). As we reported previously 
(Gomez and Daniotti, 2005) for CHO-K1 cells, doubly acylated H-
RasWT was localized at the plasma membrane and recycling endo-
somes (colocalizing with endocytosed transferrin) and showed no 
colocalization with the Golgi complex markers GalNAc-T (trans-
Golgi network [TGN]) and Sial-T2 (proximal Golgi complex; Figure 
1Bi and Supplemental Figure S1). In contrast, single-acylation mu-
tants of H-Ras revealed a different pattern of subcellular localization. 
H-Ras(C181S) was mostly present in Golgi membranes and only 
minimally localized at the plasma membrane, whereas H-Ras(C184S) 
was present at both the plasma membrane and the Golgi complex. 
However, neither was detected in recycling endosomes (Figure 1B, ii 
and iii, and Supplemental Figure S1). In contrast, nonacylated H-
Ras(C181,184S) localization largely extended throughout the cell 
and was associated mainly with the endoplasmic reticulum and 
Golgi complex, as reported previously (Figure 1Biv; Choy et al., 
1999). These results agree with our previous investigation showing 
that dual acylation constitutes a sorting signal for recycling endo-
some localization (Trenchi et al., 2009) and reveals critical differences 
in the role of single-acylation sites of H-Ras in its Golgi complex 
versus plasma membrane localization. A similar pattern of organelle 
distribution for H-Ras(C181S) and H-Ras(C184S) was observed in 
COS-7, HeLa, and NIH 3T3 cells (Supplemental Figure S2, A–C).
We then explored the possibility that the differences observed in 
subcellular distribution could be a consequence of alterations in 
membrane association and/or a posttranslational modification of H-
Ras. To test this, we performed biochemical experiments to analyze 
the membrane binding and extent of lipidation of H-Ras when ex-
pressed in CHO-K1 cells. Our results demonstrated that H-Ras(WT), 
H-Ras(C181S), H-Ras(C184S), and H-Ras (C181S,C184S) were pref-
erentially bound to cellular membranes, as these partitioned mostly 
to the pellet fraction after ultracentrifugation at 400,000 × g (Figure 
1C). In addition, Triton X-114 partition assays of membrane and cy-
tosolic fractions revealed that all of the H-Ras proteins were en-
riched in the detergent phase, which indicates the highly hydropho-
bic character of the protein conferred by farnesylation and/or 
S-acylation (Figure 1D; Gomez and Daniotti, 2005).
Because live-cell imaging experiments suggested that H-
Ras(C181S) and H-Ras(C184S) behave differently from the nonacyl-
atable H-Ras(C181,184S), these mutants might be posttranslation-
ally S-acylated. To try to confirm this, we used two independent 
methods. First, we directly evaluated the S-acylation of these mu-
tants (and H-RasWT as control) by acyl biotinyl exchange (ABE) assays 
(Wan et al., 2007), which demonstrated the acylation of the H-
Ras(C181S) and H-Ras(C184S) versions (Figure 1E). Second, we per-
formed a synchronized protein expression protocol (Trenchi et al., 
2009) in the presence of the S-acylation inhibitor 2-bromopalmitate 
(2-BP, 50 µM; Figure 1F) to impede the palmitoylation of newly 
within the hypervariable region. In particular, H-Ras is posttransla-
tionally S-acylated at cysteines 181 and 184, and N-Ras is S-acylated 
at cysteine 184, whereas K-Ras4B is not further modified with lipids 
but contains a polybasic domain with a binding capacity to anionic 
phospholipids. K-Ras4A is actually unique among the four Ras pro-
teins in that it possesses a dual membrane-targeting motif of both 
an S-acylated cysteine and a polybasic region (Silvius et al., 2006; 
Gomez and Daniotti, 2007; Cox et al., 2015).
Beyond its role as a second signal for membrane binding, S-acyl-
ation is an important posttranslational modification on H-Ras, N-Ras 
and K-Ras4A isoforms, as it is the only lipid modification that is re-
versible by the action of palmitoyltransferases (PATs), which catalyze 
S-acylation, and also acyl-protein thioesterases (APTs), which cata-
lyze S-deacylation. Moreover, the concerted action of PATs and APTs 
makes it possible for S-acylated proteins to undergo several cycles 
of acylation/deacylation during their lifetimes (Salaun et al., 2010; 
Chamberlain and Shipston, 2015), which is critical for the adequate 
localization and trafficking of S-acylated Ras isoforms (Goodwin 
et al., 2005; Rocks et al., 2005; Tomatis et al., 2010).
S-acylation of H-Ras in mammalian cells has been shown to de-
pend on DHHC9/GCP16 palmitoyl transferase (Lobo et al., 2002; 
Swarthout et al., 2005), whereas the enzymes that catalyze its deac-
ylation are APT1 and APT2, two cytosolic APTs that have been de-
scribed to deacylate Gs α-subunit of trimeric G-proteins and H-Ras 
(Duncan and Gilman, 1998; Zeidman et al., 2009; Tomatis et al., 2010; 
Lin and Conibear, 2015b). More recently, ABHD17, a protein depal-
mitoylase, was also found to deacylate N-Ras, as well as postsynaptic 
density-95 protein (Lin and Conibear, 2015a; Yokoi et al., 2016).
Cycles of acylation and deacylation are important in regulating 
the H-Ras function (Baines et al., 2011; Verstraeten et al., 2011), with 
perturbations in the acylation/deacylation machinery of H- and N-
Ras not only affecting its subcellular distribution, but also partially 
reversing the phenotype of H-Ras–transformed epithelial cells and 
inhibiting the growth of N-Ras(G12D) mutant hematopoietic cells 
(Dekker et al., 2010; Hedberg et al., 2011; Xu et al., 2012; Spiegel 
et al., 2014). Of note, an in vivo RNA interference screen identified 
APT2 as a candidate regulator of oncogenic H-Ras–dependent ma-
lignancy (Beronja et al., 2013).
In addition to being reversible, the attachment of fatty acid to 
H-Ras by S-acylation is required for H-Ras inclusion into vesicular 
carriers, which also contributes to the overall subcellular distribution 
of palmitoylated H-Ras. The dual acylation of H-Ras has been shown 
to be required for its endosomal transport and efficient plasma 
membrane localization (Gomez and Daniotti, 2005; Goodwin et al., 
2005; Rocks et al., 2005), but mutation of acylation sites has caused 
H-Ras to accumulate in different subcellular compartments (Roy 
et al., 2005).
In spite of these recent advances in the characterization of the 
biochemistry of S-acylation and H-Ras vesicular trafficking, it is still 
unclear whether single acylation sites contribute differentially to 
processes that lead to correct H-Ras subcellular localization and 
therefore its capacity to engage subcellular signaling. Here we 
demonstrate that S-acylated cysteines 181 and 184 contribute dif-
ferentially to H-Ras membrane affinity and exhibit distinct APT sen-
sitivities and deacylation kinetics. Furthermore, single acylated H-
Ras undergoes (and to different extents) vesicular-mediated 
intracellular trafficking at the level of the post-Golgi complex, with 
the palmitoylated cysteine 184 more efficient at being incorporated 
into the Golgi to plasma membrane vesicular carriers. Of note, both 
single-acylated mutants exhibit deacylation-dependent and -inde-
pendent diffusion with rapid reversible membrane binding to differ-
ent intracellular organelles. Thus our results indicate that cysteines 
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synthesized H-Ras. Under these conditions, 
blocking of S-acylation prevented the local-
ization of H-RasWT, H-Ras(C181S), and H-
Ras(C184S) at the plasma membrane and 
redistributed them to membranes of the 
endoplasmic reticulum and the Golgi com-
plex, similarly to the observed distribution 
of nonacylatable H-Ras(C181,184S) (Figure 
1G). As expected, 2-BP did not affect the 
subcellular localization of the double-cyste-
ine mutant. These experiments confirm that 
H-Ras(C181S) and H-Ras(C184S) are S-acyl-
ated and suggest that the differences in 
subcellular distribution might be due to dif-
ferential palmitate turnover.
Because our results showed that the dual 
acylation of H-Ras is not absolutely essential 
for the protein to remain membrane at-
tached (Figure 1, B, D, and G), we then in-
vestigated whether mutation of single acyla-
tion sites would allow H-Ras still to be able 
FIGURE 1: S-acylation, membrane association, and subcellular localization of H-Ras 
palmitoylation mutants. (A) Schematic representation of H-Ras C-terminal hypervariable region 
and its posttranslational modifications. (B) CHO-K1 cells were cotransfected with H-RasWT, 
H-Ras(C181S), H-Ras(C184S), or H-Ras(C181,184S) fused to YFP (pseudocolored green in the 
insets) and Golgi markers GalNAc-T-Cherry (pseudocolored red) and Sial-T2-CFP (pseudocolored 
cyan). Then they were incubated with Alexa Fluor 647–Tf (pseudocolored magenta) and 
analyzed by fluorescence confocal microscopy. Insets, zoomed images of the indicated region, 
as well as the colocalization with the organelle markers. Scale bars, 10 µm. (C) Subcellular 
fractionation. CHO-K1 cells transfected with H-RasWT, H-Ras(C181S), H-Ras(C184S), or 
H-Ras(C181,184S) fused to YFP were lysed and ultracentrifuged, and the supernatant (S) and 
pellet (P) fractions were separated. Proteins from these fractions were Western blotted with an 
antibody to GFP. (D) Triton X-114 partition assay. CHO-K1 cells transfected with H-RasWT, 
H-Ras(C181S), H-Ras(C184S), or H-Ras(C181,184S) fused to YFP were lysed and ultracentrifuged, 
and the supernatant (S) and pellet (P) fractions were separated. Then buffer containing 1% Triton 
X-114 was added, and phase separation was induced by incubation at 37°C. Proteins from 
aqueous (A) and detergent (D) phases were Western blotted with an antibody to GFP. 
(E) S-acylation detection by ABE assay. CHO-K1 cells transiently transfected with H-RasWT, 
H-Ras(C181S), or H-Ras(C184S) fused to YFP were lysed and incubated with NEM to block free 
thiols and treated or not with hydroxylamine (HA) to hydrolyze thioester bonds. After incubation 
with HPDP-biotin, biotinylated proteins were 
pulled down with streptavidin agarose beads 
and analyzed by Western blot using an 
antibody to GFP. Samples collected before 
(Input) and after (ABE) the pull down in 
conditions without (–HA) or with (+HA) 
hydroxylamine treatment. (F) Workflow of 
the experimental procedure used in G. 
CHO-K1 cells were transfected with 
H-RasWT, H-Ras(C181S), H-Ras(C184S), or 
H-Ras(C181,184S) fused to YFP in the 
presence of cycloheximide (CHX). At 30 min 
before CHX withdrawal, cells were incubated 
with 50 µM 2-BP or DMSO (vehicle, Ctrl). At 
0 h, CHX was removed, and cells were further 
incubated with 2-BP or DMSO for 9 h. Finally, 
cells were analyzed by fluorescence confocal 
microscopy. (G) Representative images of 
H-RasWT, H-Ras(C181S), H-Ras(C184S), and 
H-Ras(C181,184S) fused to YFP, showing the 
effect of 50 µM 2-BP or DMSO (Ctrl) on 
subcellular distribution. Scale bars, 10 µm. 
(H) CHO-K1 cells nontransfected (Ctrl) or 
transfected with H-RasG12V, H-RasG12V 
(C181S), or H-RasG12V (C184S)-YFP were 
harvested in serum-free medium and 
analyzed by Western blot. A control 
condition was performed by incubating the 
cells with 10% FBS for 10 min to reveal the 
Erk1/2 activation (second line, Ctrl + FBS). 
The blots show the signal obtained by 
incubation with specific antibodies to 
phosphorylated Erk1/2 (p-Erk), total Erk 
(Erk), GFP, and tubulin. The blots are 
representative of three independent 
experiments. (I) Quantification of the 
experiment in H. Bars show mean amount 
of phosphorylated Erk relative to total Erk 
(arbitrary units [a.u.]) obtained in three 
independent experiments ± SEM. These 
values were relativized to the pErk/Erk of the 
Ctrl + FBS sample (shown as a dotted line). 
*p < 0.05; ***p < 0.001.
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to engage downstream signaling. To carry 
this out, we generated single-acylation mu-
tants in a background of a constitutively ac-
tive H-Ras mutant (H-RasG12V), a mutation 
largely known to impair intrinsic GAP-medi-
ated GTPase function (Hobbs et al., 2016). 
Transfected as well as control CHO-K1 cells 
were harvested in serum-free medium and 
then processed for Western blot analysis. 
We observed that there was no difference 
between the phosphorylation state of 
Erk1/2 in cells expressing dually acylated H-
RasG12V or monoacylated H-RasG12V mu-
tants (Figure 1, H and I). Of note, endomem-
brane distribution of the oncogenic versions 
of dually and monoacylated H-Ras was simi-
lar to the localization of their nonmutated 
counterparts (Supplemental Figure S3).
Taken together, the results show that H-
RasWT, H-Ras(C181S), and H-Ras(C184S) ex-
hibit different subcellular distributions, are 
S-acylated, and associate to membranes 
and activate Erk1/2 to the same extent. 
These agree with the notion that H-Ras 
signaling can proceed on endomembranes 
(Chiu et al., 2002; Arozarena et al., 2011; 
Agudo-Ibanez et al., 2015).
Acyl-protein thioesterases deacylate 
H-Ras(C181S) and H-Ras(C184S) 
mutants with different kinetics at 
the plasma membrane
Having demonstrated that 1) differentially 
acylated versions of H-Ras have different 
subcellular localizations, 2) these differences 
depend on the incorporation and position 
of fatty acids, and 3) oncogenic versions of 
H-Ras acylation mutants are able to stimu-
late downstream effectors, we studied in 
more detail the deacylation process of these 
proteins. CHO-K1 cells transiently express-
ing H-Ras(C181S) or H-Ras(C184S) were in-
cubated with cycloheximide for 1 h (to pre-
vent protein synthesis) and then treated with 
50 µM 2-BP to inhibit the PATs but not the 
thioesterases activities, as previously dem-
onstrated for GAP-43 (Pedro et al., 2013) 
and biochemically for H-Ras (Supplemental 
Figure S4). At the same time, we monitored 
H-Ras subcellular localization by live-cell im-
aging (Figure 2, A and B). We observed that 
H-Ras(C181S) fluorescence on the plasma 
membrane decayed significantly, with a 
FIGURE 2: APT-driven deacylation of monoacylated versions of H-Ras in the plasma membrane 
and Golgi complex. (A, B) CHO-K1 cells were transfected to express H-Ras(C181S) or 
H-Ras(C184S)-YFP and analyzed by live-cell confocal fluorescence microscopy. At the beginning 
of the experiment, 50 µM 2-BP was added and maintained in the medium during all the 
procedure. Representative images taken at the start (0 min) and end (150 min) of each 
experiment. Scale bars, 10 µm. (C–F) Quantification of the obtained images (for details, see 
Materials and Methods). Bars represent the fluorescence in plasma membrane (PM) or Golgi 
complex relative to the cytoplasm fluorescence at different times after the addition of 2-BP. 
Data are expressed as mean ± SEM of two to six experiments performed independently. 
(G, H) CHO-K1 cells were cotransfected to express APT1-CFP or APT2-CFP (donor) and H-RasWT 
or H-Ras(C181,184S)-YFP (acceptor), and the FRET experiment was performed. FRET efficiency 
was evaluated by acceptor-sensitized emission (right). Representative cells undergoing FRET, 
with the respective scale of colors indicated in each FRET panel. Scale bars, 10 µm. 
(I) Quantification of FRET experiments in G and H. Values of FRET efficiency represented as 
percentages. H-RasWT + CFP and H-Ras(C181,184S) + CFP were used as negative controls. A 
representative experiment from three experiments performed independently. The number of 
cells analyzed in each case was ∼40. (J, K) CHO-K1 cells were cotransfected to express 
H-Ras(C181S) or H-Ras(C184S)-YFP and APT1-CFP or APT2-CFP (pseudocolored red) and 
analyzed by live-cell confocal fluorescence microscopy. At the beginning of the experiment, 
50 µM 2-BP was added and maintained in the medium during all the procedure. Representative 
images taken at the start (0 min) and end (120 min) of each experiment. Insets, expression of 
APTs. Scale bars, 10 µm. (L–O) Quantification of the images (for details, see Materials and 
Methods). Bars represent the fluorescence of 
each protein in plasma membrane (PM) or 
Golgi complex relative to the cytoplasm 
fluorescence at different times after the 
addition of 2-BP. Data are expressed as mean 
± SEM of two to six experiments performed 
independently. ns, nonsignificant; *p < 0.05; 
**p < 0.01; ***p < 0.001; ****p < 0.0001.
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action of APTs, as we previously found for single-acylation mutants 
of GAP-43 (Tomatis et al., 2010). To test whether this is the case for 
H-Ras single-acylation mutants, we measured their desorption ki-
netics from the plasma membrane and Golgi complex of cells over-
expressing APT1 or APT2 in the presence of 2-BP (Figure 2, J and K). 
First, we analyzed the deacylation kinetics of H-Ras(C181S) at the 
plasma membrane, where this protein was barely localized (Figure 
2L). A loss of signal on this membrane was evident at the analyzed 
times, although there was no increase in the deacylation kinetics, 
due to the overexpression of the APTs (compare with results from 
Figure 2C). This could have been a consequence of the small 
amount of plasma membrane–bound H-Ras(C181S) associated with 
a relatively high level of endogenous APT2 activity. In addition, no 
significant changes in the deacylation rate of H-Ras(C181S) at the 
Golgi complex were observed in APT-overexpressing cells com-
pared to cells treated with only 2-BP.
In contrast, we found that overexpression of APT1 or APT2 sig-
nificantly increased the deacylation kinetics at the plasma mem-
brane of H-Ras(C184S), with it being faster in cells that overex-
pressed the latter, thus suggesting a slight preference of APT2 for 
this substrate (Figure 2N). In this case, Golgi complex fluorescence 
did not significantly change over time (Figure 2O), whereas associa-
tion of H-Ras(C184S) with membranes from the endoplasmic reticu-
lum clearly increased, indicating a direct connection between this 
organelle and the plasma membrane or, eventually, via a rapid and 
transient passage through the Golgi complex, establishing an equi-
librium with the endoplasmic reticulum pool. However, it cannot be 
discarded that H-Ras(C181S) and H-Ras(C184S) could also be sub-
strates for other thioesterases.
Individual cysteine groups contribute differentially 
to the Golgi exiting of H-Ras
In addition to the differences in deacylation kinetics and sensitivity 
to APT-mediated deacylation, a key aspect in the behavior of H-
Ras(C181S) and H-Ras(C184S) is their relative expression in the 
Golgi complex and plasma membrane compartments, which sug-
gests that acylation on the cysteine residues C181 and C184 con-
tributes differentially to the dynamics of Golgi entrance and/or 
exiting. An important observation in relation to this phenomenon 
is the effect of 2-BP on the subcellular distribution of H-Ras(C181S) 
and H-Ras(C184S) (Figure 2, D and F). Although deacylation of 
both proteins is evident under these conditions (with an increase in 
the endoplasmic reticulum pool being observed), the persistence 
of the proteins’ Golgi fraction under these circumstances is differ-
ent. In particular, the Golgi/cytoplasm ratio decreases faster over 
time for H-Ras(C181S) than for H-Ras(C184S) (Figure 2, D and F), 
suggesting that H-Ras(C181S) could be incorporated into the 
Golgi complex to plasma membrane vesicular carriers and/or de-
tach from the Golgi membranes more efficiently. To test this quan-
titatively, we measured the dynamics of Golgi complex exiting of 
the single-acylated protein pool that localizes in this compartment 
by fluorescence loss in photobleaching (FLIP), as we previously de-
scribed for diacylated proteins (Trenchi et al., 2009). CHO-K1 cells 
were cotransfected to express H-Ras(C181S)- or H-Ras(C184S)-
YFP, and GalNAc-T-Cherry was used as an internal control and 
Golgi complex marker; cells were treated with cycloheximide to 
inhibit protein synthesis. A small region of interest (ROI) at the 
plasma membrane was selected and bleached by irradiation every 
2 min for 1 h, and the fluorescence belonging to the Golgi com-
plex was quantified (Figure 3A). We observed an important de-
crease in the signal from the fluorescent H-Ras(C181S) and H-
Ras(C184S) attached at the Golgi complex, which reflected the 
simultaneous increase in its cytoplasmic pool (probably endoplas-
mic reticulum) over time, suggesting that this pool of H-Ras mutant 
was completely deacylated within the time scale of our experiments 
(∼120 min; Figure 2C). However, the most significant pool of this 
protein, localized at the Golgi complex, was still present, although 
affected by the addition of 2-BP (Figure 2D). A similar result was 
observed using cerulenin, a fungal inhibitor of PATs and hence of 
H-Ras (Lawrence et al., 1999; Chen et al., 2003; unpublished data). 
Regarding H-Ras(C184S), its plasma membrane and Golgi complex 
association clearly decreased throughout the experiment, indicating 
depalmitoylation activity (Figure 2, E and F). Nevertheless, this 
deacylation process seemed to be less efficient than that observed 
for the H-Ras(C181S) mutant in both subcellular localizations. These 
experiments were further complemented by analyzing the Manders 
overlap coefficient between H-Ras(C181S, C184S) and organelle 
markers (plasma membrane and Golgi complex markers) before and 
after 2-BP treatment (Supplemental Figure S5). As observed in Sup-
plemental Figure S5, the degree of overlap between monoacylated 
H-Ras and the plasma membrane marker was drastically reduced 
after addition of 2-BP. In contrast, there was no significant change in 
pixel overlap at the Golgi complex at the beginning or end of incu-
bation with the inhibitor, suggesting the presence of a mixed pool 
of H-Ras molecules (acylated and deacylated) in this compartment. 
The results indicate that deacylation at the Golgi complex might not 
be as efficient as at the plasma membrane for H-Ras(C181S) and 
that deacylation on the C181 and C184 residues is not biochemi-
cally and functionally equivalent, with deacylation on H-Ras(C181S) 
being more significant than for H-Ras(C184S).
One possible explanation for the different deacylation kinetics of 
H-Ras at the plasma membrane compared with endomembrane 
could be differential interaction between APTs and their substrates 
at these two subcellular locations in CHO-K1 cells. Although both 
APT1 and APT2 are able to deacylate Ras (Dekker et al., 2010; 
Tomatis et al., 2010), whether they interact differentially with H-
RasWT and/or interact with it at different subcellular locations remain 
to be determined. Thus, to evaluate first the potential role of these 
proteins on H-Ras deacylation, we performed Förster resonance en-
ergy transfer (FRET) experiments to investigate the physical interac-
tion between the cytosolic APTs and plasma membrane-associated 
H-RasWT. For FRET to occur, proteins attached to appropriate fluoro-
phores must lie within 1–10 nm of each other for energy transfer to 
take place, which could be interpreted as a protein–protein interac-
tion because this takes place on a similar spatial scale. Therefore we 
coexpressed H-Ras–yellow fluorescent protein (YFP) with either 
APT1–cyan fluorescent protein (CFP) or APT2-CFP in CHO-K1 cells, 
and, as negative control, we coexpressed H-Ras–YFP and cytosolic 
CFP. We found that both cytosolic thioesterases physically inter-
acted with H-RasWT, principally at the plasma membrane, with some 
weak FRET signals observed on other intracellular compartments, 
such as recycling endosomes (Gomez and Daniotti, 2005), where 
H-RasWT localized at steady state (Figure 2, G and I). Of note, neither 
APT1 nor APT2 underwent FRET with the nonpalmitoylated mutant 
H-Ras(C181,184S) (Figure 2, G and I). These results are consistent 
with the idea that H-Ras is a substrate of APT1 and APT2 (Dekker 
et al., 2010; Tomatis et al., 2010). Moreover, these findings suggest 
that deacylation of H-RasWT occurs mainly at the plasma membrane 
and/or that a palmitoylated substrate is necessary for the APTs to 
interact with H-Ras.
Differences in deacylation kinetics at the same subcellular com-
partment (i.e., Golgi complex or plasma membrane) were also ob-
served when we analyzed H-Ras(C181S) and H-Ras(C184S), which 
suggests that these mutants may exhibit different sensitivities to the 
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fact that proteins were being transported 
to the plasma membrane (Figure 3, B and 
C). However, this occurred with different 
dynamics for H-Ras(C181S): faster exit 
( = ±t 5.5 0.2 min1/2 ) was noted than for H-
Ras(C184S) ( = ±t 8.7 0.4 min1/2 ). This result 
is in agreement with our hypothesis that ac-
ylation of these residues contributes differ-
entially to the dynamics of H-Ras trafficking.
To confirm these observations, we mea-
sured the residence time of H-Ras mutants 
at the Golgi complex in photoactivation 
experiments by analyzing the half-life of 
fluorescence decay of photoactivated H-
Ras(C181S) and H-Ras(C184S) fused to pho-
toactivable green fluorescent protein 
(PA-GFP; Patterson and Lippincott-Schwartz, 
2004; Rocks et al., 2005). Photoactivation 
experiments allow the residence time to be 
measured of a “snapshot pool” of H-Ras 
present at the Golgi complex. In the case of 
Ras proteins, this snapshot could be nonac-
ylated or acylated proteins, and thus the ki-
netics of decay will reflect the residence half-
life of these different protein populations. 
Our results showed that photoactivation of 
H-Ras(C181S) at the Golgi complex resulted 
FIGURE 3: Traffic of monoacylated H-Ras versions from the Golgi complex. (A) FLIP 
experiment. CHO-K1 cells were cotransfected to express H-Ras(C181S) or H-Ras(C184S)-YFP 
and GalNAc-T-Cherry (Golgi complex marker, pseudocolored red) and treated with 
cycloheximide for 1 h before start of the experiment. Representative images at different times 
(prebleach and 10, 30, and 60 min). Repeated photobleaching was performed at the indicated 
area (white circle) every 2 min. Insets, zoomed images of the expression of GalNAc-T-Cherry in 
the indicated area. Scale bars, 10 µm. (B, C) Quantification of experiments in A. Golgi complex 
fluorescence was quantified as indicated in Materials and Methods. Data are expressed as mean 
± SEM of three independent experiments. Red dotted line represents adjustment of the data to 
a one-phase decay equation. (D, E) Photoactivation at the Golgi complex. CHO-K1 cells were 
cotransfected to express H-Ras(C181S)-PAGFP or H-Ras(C184S)-PAGFP (pseudocolored gray) 
and GalNAc-T-Cherry (pseudocolored red). The area to photoactivate was chosen according to 
the expression of the Golgi marker. In the experiment with 2-BP (E), the inhibitor was added 
15–30 min before start of image acquisition and maintained in the medium during the time of 
the experiment. Representative images at different times (prephotoactivation and 0, 5, 10, and 
15 min). Bottom right, insets showing 
expression of GalNAc-T-Cherry over time. 
Top right, overexposed images to evidence 
the subcellular localization of fluorescence-
activated H-Ras(C181S) or H-Ras(C184S). 
Scale bars, 10 µm. (F, G) Quantification of 
D and E, respectively. Golgi complex 
fluorescence was quantified as indicated in 
Materials and Methods. Data are expressed 
as mean ± SEM of three or four independent 
experiments. Red dotted line represents the 
adjustment of each data set to a one-phase 
decay equation. (H) Half-life of the protein at 
the Golgi complex calculated from F and G. 
(I, J) Photoactivation at the endoplasmic 
reticulum/cytosol. CHO-K1 cells were 
cotransfected to express H-Ras(C181S)-
PAGFP or H-Ras(C184S)-PAGFP 
(pseudocolored gray) and GalNAc-T-Cherry 
(pseudocolored red) or ST3Gal-II-Cherry 
(pseudocolored red). The area to 
photoactivate is indicated with a white circle. 
In the experiment with 2-BP (J), the inhibitor 
was added 15–30 min before start of image 
acquisition and maintained in the medium 
during the time of the experiment. 
Cycloheximide was added 1 h before start 
of the experiment and maintained in the 
medium during the experiment. Repetitive 
photoactivation was performed in the 
selected area every 2 min. Representative 
images at different times (prephotoactivation 
and 0 and 15 min). Insets, expression of 
GalNAc-T-Cherry or ST3Gal-II-Cherry over 
time. Scale bars, 10 µm.
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to express the Golgi marker GalNAc-T-Cherry with H-Ras(C181S)- or 
H-Ras(C184S)-YFP and treated with cycloheximide to inhibit protein 
synthesis. Then the Golgi complex was photobleached by confocal 
laser microscopy and the region monitored for fluorescence recov-
ery for 15 min. As shown in Figure 4A, H-Ras(C181S) was highly 
concentrated at the Golgi complex, colocalizing with GalNAc-T. 
After focal irradiation, the fluorescence was considerably reduced 
and began to rapidly reappear at this location (Figure 4A, top). 
Quantification of this event showed that the fluorescence recovered 
with a half-life (t1/2) of 3.2 ± 0.4 min and a mobile fraction of 18%. 
Furthermore, fluorescence recovery on the Golgi complex seemed 
not to depend on PAT activity, because the pharmacological treat-
ment of the cell with 50 µM 2-BP resulted in a fluorescence recovery 
with t 5 1 min1/2 = ±  (Figure 4B), with no significant changes in the 
mobile fraction, in contrast to that observed for diacylated H-Ras in 
Madin–Darby canine kidney cells (Rocks et al., 2005). This result sug-
gests that H-Ras(C181S) was able to exchange with pools of the 
protein located elsewhere in the cell and that the observed Golgi 
complex pool of this protein did not necessarily reflect a pool that 
was being acylated by PATs, which concurs with our observation that 
nonpalmitoylated, photoactivated H-Ras(C181S) can be exchanged 
between the Golgi and endoplasmic reticulum. In contrast, FRAP 
experiments with H-Ras(C184S) resulted in a recovery of the fluores-
cence at the Golgi complex with t 3.5 0.7 min1/2 = ±  (Figure 4A, 
bottom) and a 17% mobile fraction. In the presence of 2-BP, we 
observed that the recovery occurred with t 2.8 0.5 min1/2 = ±  but 
with a significantly increased mobile fraction (∼50% of the initial; 
Figure 4C), suggesting that under these conditions, deacylated H-
Ras contributed more to the recovery rates observed.
Cycloheximide inhibits the FK506-binding protein (FKBP) family 
of prolyl isomerases (Christner et al., 1999). FKBP12, a member of the 
FKBP family, binds to H-Ras in a palmitoylation-dependent manner 
and promotes depalmitoylation in a manner dependent on proline 
179 (Ahearn et al., 2011). In particular, FKBP12 only binds diacylated 
H-Ras, and association with nonpalmitoylated or monopalmitoylated 
H-Ras (C181S and C184S) was drastically reduced or inhibited, indi-
cating that cycloheximide might not affect deacylation of these acyla-
tion mutants. Nonetheless, and considering that cycloheximide was 
used in our studies to inhibit protein synthesis, we performed con-
trols by FRAP experiments in the presence of puromycin, which is a 
translation inhibitor lacking prolyl isomerase inhibitor activity (Ahearn 
et al., 2011). As seen in Supplemental Figure S6, the kinetics of pho-
tobleaching recovery of H-Ras(C181S) and H-Ras(C184S) at the Golgi 
complex were similar in the presence of cycloheximide and puromy-
cin, denying a modulatory effect of FKBP12 on the trafficking of these 
monoacylated mutants.
Next we sought to investigate the contribution of the plasma 
membrane pool of H-Ras to the fluorescence recovery at the Golgi 
complex. FRAP experiments were performed in the presence of tannic 
acid, a nonpermeable mild fixative that functionally impairs the plasma 
membrane without affecting the trafficking between the organelles of 
the rest of the endomembrane system (Polishchuk et al., 2004; 
Paladino et al., 2006; Trenchi et al., 2009). Under these conditions, the 
fluorescence recovery at the Golgi complex was inhibited for both 
monoacylated mutants of H-Ras (Figure 4, B and C), demonstrating 
that a significant fraction of the proteins again reached the Golgi com-
plex, probably through exchange with the plasma membrane. More-
over, when FRAP experiments were performed for H-Ras(C184S) in 
the presence of tannic acid and 2-BP, fixation at the plasma mem-
brane blocked the increase in the mobile fraction caused by 2-BP, re-
vealing again that deacylation at the plasma membrane contributed 
to the steady-state Golgi pool of H-Ras(C184S). In addition, because 
in a rapid decrease of fluorescence in this organelle, with a half-life of 
3.3 ± 0.1 min and reaching up to a 20% of the initial value (Figure 3, 
D, F, and H). Its association with discrete structures (vesicles; Supple-
mental Movie S1) can also be observed, suggesting that the fluores-
cence at the Golgi complex was decaying because photoactivated 
molecules were incorporated efficiently into the vesicular carriers. Of 
interest, when this experiment was carried out in the presence of 
2-BP, which led to efficient depalmitoylation of this mutant, there was 
a significant reduction in the exiting of H-Ras(C181S), with a half-life 
of 3.8 ± 0.5 min and a plateau value of 50% of the initial fluorescence 
(Figure 2, E, F, and H). Moreover, we did not observe the incorpora-
tion of depalmitoylated H-Ras into vesicular carriers under these con-
ditions (Supplemental Movie S1). In fact, we noted that photoacti-
vated H-Ras(C181S) began to appear in regions that belonged to the 
endoplasmic reticulum near the Golgi complex before rapidly diffus-
ing throughout the entire organelle (see the overexposed box in 
Figure 3E). This suggests that although H-Ras(C181S) requires palmi-
toylation for its incorporation into carriers before Golgi complex exit-
ing, this is not a requirement for Golgi exchange with the endoplas-
mic reticulum. A similar behavior was previously described for the 
diacylated, GABA-synthesizing enzyme GAD65 (Kanaani et al., 
2008). This strengthens the concept that under 2-BP treatment, the 
Golgi pool of H-Ras(C181S) is mostly nonacylated and that this pool 
of protein can rapidly redistribute (mainly to the endoplasmic reticu-
lum) when photoactivated at the Golgi complex (Rocks et al., 2010).
A different behavior was observed for H-Ras(C184S) when we ana-
lyzed the kinetics of fluorescence decay after photoactivation at the 
Golgi complex. With respect to H-Ras(C181S), a vesicular exit from 
this organelle was also evidenced for H-Ras(C184S), although with 
significantly slower kinetics ( = ±t 5.0 0.2 min1/2 ), which agreed with 
our previous FLIP results (Figure 3, D, G, and H, and Supplemental 
Movie S2). However, in the presence of 2-BP, the mobile fraction was 
not significantly different (as occurred the case of H-Ras(C181S)), but 
with significantly slower half-life (Figure 3E and Supplemental Movie 
S2). Given the fact that at steady state, H-Ras(C184S) is palmitoylated 
(Figure 1E) but with slower deacylation kinetics than H-Ras(C181S), 
this suggests that the percentages of acylated H-Ras (C184S) under 
control and 2-BP conditions are not dramatically different, and there-
fore similar decay curves should be expected as we observed in our 
experiments. Note that the decay rate was slower for H-Ras(C184S), 
indicating that the efficiency at which this is incorporated into vesicu-
lar carriers is lower than that of H-Ras(C181S). Finally, a repetitive pho-
toactivation of H-Ras(C181S) and H-Ras(C184S) outside the Golgi 
complex (in a region that corresponded to the endoplasmic reticulum 
and cytosol) resulted in an accumulation of the proteins in this organ-
elle, even in the presence of 2-BP (Figure 3, I and J). These results 
support the observation that a rapid and dynamic exchange exists 
between the endoplasmic reticulum and Golgi complex and that this 
exchange is independent of S-acylation.
Deacylation on individual cysteine groups contributes 
differentially to the Golgi pool of H-Ras
Our previous results showed that H-Ras single-acylated mutants are 
deacylated at the plasma membrane and travel from the Golgi com-
plex to the plasma membrane and/or endoplasmic reticulum with 
differential kinetics and through different trafficking processes. 
Next we studied the retrograde transport by testing whether deac-
ylation at the plasma membrane contributes directly to the Golgi 
complex pool, as observed for these proteins at steady state. To 
carry this out, we performed fluorescence recovery after photo-
bleaching (FRAP) of the pool of the monoacylated H-Ras proteins 
associated to the Golgi complex. CHO-K1 cells were cotransfected 
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membrane, which in turn results in the gen-
eration of second messengers or activation 
of specific target proteins (Di Fiore and Gill, 
1999). Under this scenario, endocytosis was 
previously considered to be involved in the 
termination of a signal by removing the re-
ceptor from the cell surface and promoting 
uncoupling of the ligand–receptor complex. 
In recent years, this paradigm has changed 
completely because of new evidence linking 
endocytosis and trafficking to the regulation 
of signal transduction. Indeed, complete sig-
nal transduction platforms (i.e., Ras, Raf-1, 
phosphorylated MEK, and phosphorylated 
mitogen-activated protein kinase) were 
found to be associated with endocytic trans-
port vesicles and endosomes after stimula-
tion with epidermal growth factor and insulin 
(Pol et al., 1998; Rizzo et al., 2000, 2001; 
Jiang and Sorkin, 2002). However, the cellu-
lar and molecular mechanisms that govern 
intracellular distribution of many signaling 
molecules are still not well understood.
In the case of H-Ras, a dynamic turnover 
of palmitate was found to regulate the intra-
cellular trafficking of this protein to and from 
the Golgi complex by shifting between non-
vesicular and vesicular modes of transport 
(Goodwin et al., 2005; Rocks et al., 2005). 
We also provided evidence that H-Ras is en-
docytosed and delivered to the endocytic 
recycling compartment in Rab5- and Rab11-
dependent vesicular transport (Gomez and 
Daniotti, 2005). However, due to the lack of 
a complete effect of GDP-bound Rab mu-
tants on the internalization of H-Ras, we hy-
pothesized that a small GTPase could be 
internalized using alternative and simultane-
ous pathways in which the rate of acylation/
deacylation might regulate these processes. 
In the present study, we focused on APT-
driven deacylation of differentially acylated 
species of H-Ras and how it could affect the 
dynamic and intracellular trafficking of this 
GTPase.
Although experiments performed on different cell lines indicated 
that H-Ras S-acylation is not absolutely essential for the protein to 
remain membrane attached, it is a necessary condition for endo-
membrane localization. In fact, both the stoichiometry and the posi-
tion of fatty acids in H-Ras had a great influence on the cell type–de-
pendent distribution. In particular, we found that these sites exhibit 
a differential preference for APTs and for incorporation into vesicular 
carriers. This confirms a previous hypothesis that hydrophobicity of 
the fatty acid and prenyl groups, as well as the spacing between 
them, is relevant for Ras membrane association and trafficking (Roy 
et al., 2005). Supporting these observations, a theoretical study 
showed that cysteine 181-palmitate and cysteine 186-farnesyl alone 
provide a sufficient hydrophobic force for tight membrane binding 
of H-Ras, whereas palmitoyl at cysteine 184 does not provide extra 
affinity but contributes to lateral membrane segregation (Gorfe and 
McCammon, 2008), which in cells might affect its incorporation into 
vesicular carriers. Nevertheless, despite their different subcellular 
tannic acid also perturbs endocytic trafficking, vesicular transport of 
monoacylated H-Ras mutants between the plasma membrane and 
the Golgi complex could also be contributing.
Finally, we performed experiments using the inhibitor palmos-
tatin B, a β-lactone that forms a covalent complex with APT1, APT2, 
and other serine hydrolases (Dekker et al., 2010; Rusch et al., 2011; 
Lin and Conibear, 2015a). The presence of the thioesterase inhibitor 
clearly decreased the rate of retrieval of monoacylated H-Ras from 
plasma membrane to Golgi complex, as monitored by FRAP experi-
ments (Figure 4D). Thus the results reinforce the notion that both 
deacylation at the plasma membrane and a vesicular transport are 
primary processes for Golgi complex trafficking.
DISCUSSION
According to the classical signal transduction models, stimulation of 
growth factor receptors at the cell surface leads to the activation 
and accumulation of components in the inner leaflet of the plasma 
FIGURE 4: Traffic of monoacylated H-Ras versions to the Golgi complex. (A) FRAP experiment. 
CHO-K1 cells were cotransfected to express H-Ras(C181S) or H-Ras(C184S)-YFP and the Golgi 
marker GalNAc-T-Cherry (not shown) and treated with cycloheximide for 1 h before start of the 
experiment. Representative images at different times (prebleach and 0, 5, 10, and 15 min). The 
area photobleached is indicated by a white circle. Images were taken every 30 s for 15 min after 
photobleaching. Scale bars, 10 µm. (B, C) FRAP experiments were performed in the presence of 
2-BP and tannic acid. In the experiments with 2-BP, the inhibitor was added 15 min before start 
of image acquisition and maintained in the medium during the time of the experiment. Tannic 
acid was added when indicated to a final concentration of 1%. The photobleached area 
colocalizes with the Golgi marker, and images were taken every 30 s for 15 min after the 
photobleaching. Golgi complex fluorescence was quantified as indicated in Materials and 
Methods. Bars plots show the amount of Golgi fluorescence at the end of the experiment for 
three to six experiments performed independently. (D) FRAP experiments were performed in 
the presence of the β-lactone APT inhibitor palmostatin B. CHO-K1 cells were cotransfected to 
express H-Ras(C181S) or H-Ras(C184S)-YFP and the Golgi marker GalNAc-T-Cherry and treated 
with 10 µM palmostatin B for 15 min before start of the image acquisition and maintained in the 
medium during the time of the experiment. The photobleached area colocalizes with the Golgi 
marker, and images were taken every 15 s during 15 min after the photobleaching. Golgi 
complex fluorescence was quantified as indicated in Materials and Methods. Bars plots show the 
amount of Golgi fluorescence at the end of the experiment for six experiments performed 
independently. The values are expressed as a percentage of the control experiment (without 
palmostatin B, taken as 100% and showed as a dotted line).
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contribution of the deacylation process in retrograde trafficking of 
monoacylated H-Ras mutants.
Taken together, our results show that the interplay between PAT 
and APT activities, as well as protein stability, can result in a hetero-
geneous distribution of acylated species whose physiological or 
pathological implications have been underestimated and poorly 
studied mainly due to technical limitations that make it difficult to 
obtain information on the fractional or total amount of protein that 
is fully or partially S-acylated. The first and only antecedent in this 
regard was reported by Resh and coworkers, who demonstrated by 
mass spectrometry that about one-third of the total GAP-43 popula-
tion is monoacylated or dually S-acylated at the steady state in vivo 
(Liang et al., 2002). More recently, mathematical modeling com-
bined with experimental determinations predicted that calnexin, a 
potentially diacylated type I transmembrane protein, is either fully 
acylated or not acylated, whereas single-acylated species do not 
become significantly populated, due to a high rate of depalmi-
toylation (Dallavilla et al., 2016). This might also be the case for H-
Ras because a biochemical approach has recently shown the coex-
istence of this diacylated and nonacylated protein in neurons, 
whereas the monopalmitoylated species do not seem to be present 
in the analyzed cells (Yokoi et al., 2016). Nevertheless, we hypothe-
size that single-acylated H-Ras must exist, at least transiently, when 
nascent Ras is being modified. Given that our data now show that 
single-acylation sites have different deacylation kinetics and exhibit 
different efficiencies of incorporation into appropriate vesicular car-
riers, we expect that incorporating this information into new numeri-
cal models will help to obtain a better understanding of the subcel-
lular distribution of dually acylated H-Ras.
Summing up, our results indicate that each fatty acid moiety 
provides singular information for the spatial organization of H-Ras 
and suggest differential accessibility of fatty acids to APTs. Thus 
modulation of thioesterase activity in a particular cellular context, 
both physiological and pathological, could be relevant to orches-
trate the type and dynamics of the intracellular transport of acyl-
ated isoforms of H-Ras (see the proposed trafficking model in 
Figure 5) and, as a consequence, influence the correct connection 
of the small GTPase with downstream signaling molecules. As men-
tioned earlier, the functional implication of differentially acylated 
H-Ras has been underestimated and poorly explored, but in light of 
our results, their transient or more permanent presence in different 
cellular contexts, associated with their dynamism and capacity to 
activate downstream effectors, should definitively be taken into 




The expression vectors pECFP-C1 (ECFP is enhanced CFP), pEYFP-
C1 (EYFP is enhanced YFP), and pmCherry-C1 were obtained from 
Clontech. Expression plasmids for H-Ras-YFP, N27GalNAc-T-Cherry, 
Sial-T2-CFP, APT1-CFP, APT1-Cherry, APT2-CFP, APT2-Cherry, and 
ST3Gal-II-Cherry were previously described (Giraudo et al., 1999; 
Gomez and Daniotti, 2005; Trenchi et al., 2009; Tomatis et al., 2010; 
Pedro et al., 2013; Ruggiero et al., 2015). Monoacylated and nonac-
ylated mutants, as well as constitutively active H-RasG12V proteins, 
were constructed by PCR using H-Ras as a template and the appro-
priate primers.
Cell culture and DNA transfection
CHO-K1 cells (American Type Culture Collection, Manassas, VA) 
were maintained at 37°C and 5% CO2 in DMEM supplemented with 
localizations, the oncogenic active mutants (G12V) of H-Ras, H-
Ras(C181S), and H-Ras(C184S) were capable of activating Erk1/2 to 
the same extent. From these findings, we speculated that transient 
binding to membranes (not readily visible in fixed samples) could be 
a full requirement for wild-type and oncogenic versions of H-Ras 
acylation mutants (although mostly mislocalized) to become acti-
vated and interact with effectors.
As mentioned earlier, cysteines 181 and 184 also showed differ-
ent susceptibilities to the action of APTs, in particular at the plasma 
membrane. Time-lapse in vivo experiments revealed that in cells 
treated with the S-acylation inhibitor (2-BP) or up-expressing APT1 
or APT2, the plasma membrane and Golgi complex pools of H-Ras 
have acylation/deacylation cycles with different dynamics associ-
ated with a fraction of nonpalmitoylated H-Ras attached to the 
Golgi complex. Furthermore, monoacylated H-Ras showed a faster 
deacylation dynamic than double-palmitoylated H-Ras (unpublished 
data; Tomatis et al., 2010), similar to our results for monoacylated 
and diacylated GAP-43 (Pedro et al., 2013). Our findings also re-
vealed that APTs exhibit some degree of preference for substrates 
localized in different subcellular compartments. For H-Ras(C181S), 
which mainly accumulates at the Golgi complex, the fluorescence at 
this location is reduced over time, although with no significant dif-
ferences among cells up-expressing APT1 or APT2 and the control 
condition. This concurs with the fact that APTs interact with acylated 
Ras only at the plasma membrane and/or that the majority of this 
protein is in a deacylated state at the Golgi complex. Similarly, no 
differences in the deacylation of H-Ras(C181S) were observed at the 
plasma membrane as a result of the overexpression of the APTs, 
suggesting a saturation of endogenous APT2 enzyme activity for 
this substrate. In contrast, APT1 or APT2 overexpression increased 
the deacylation kinetics at the plasma membrane of H-Ras(C184S), 
which was faster in cells expressing the latter, which suggests a 
slight preference of APT2 for this substrate. In any case, additional 
in vivo and in vitro biochemical experiments might be carried out to 
further support the differential activities of APTs against one or an-
other S-acylated cysteine of H-Ras.
Because the extent of localization at the Golgi complex was dif-
ferent for the two monoacylated H-Ras proteins, we also character-
ized the dynamics of association of these proteins with membranes 
of this organelle. In the case of H-Ras(C181S), the association with 
the membrane from the Golgi complex seems not to depend on 
PAT activity because pharmacological treatment of the cell with the 
inhibitor 2-BP did not significantly modify FRAP. In contrast, the 
presence of S-acylation inhibitor increased both the half-time of 
fluorescence recovery and the mobile fraction of H-Ras(C184S), 
which may be explained by a larger pool of deacylated H-Ras(C184S) 
originating at the plasma membrane and arriving by diffusion to the 
Golgi complex. We also observed that the plasma membrane and 
Golgi complex pools of monoacylated H-Ras are connected and 
exchangeable and that both vesicular and diffusion transport are 
specifically involved in the retrograde journey of monoacylated H-
Ras mutants. In particular, impairment of plasma membrane fusion 
and internalization by treatment with tannic acid does affect the traf-
ficking of H-Ras(C181S) and H-Ras(C184S) from plasma membrane 
to the Golgi complex, which reveals a vesicle-mediated retrograde 
trafficking. Similarly, vesicular transport was previously demon-
strated in the trafficking of dually palmitoylated GAP-43 and wild-
type H-Ras from plasma membrane to the recycling endosomes in 
CHO-K1 cells (Gomez and Daniotti, 2005; Trenchi et al., 2009). Fur-
ther, when experiments were carried out in the presence of a thioes-
terases inhibitor, there was a marked reduction of fluorescence re-
covered at the Golgi complex, demonstrating the importance and 
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separated and extracted again with deter-
gent and aqueous solutions, respectively. 
The resulting samples were adjusted to 
equal volumes, and the detergent content 
and proteins were precipitated with 
chloroform:methanol (1:4 vol/vol) for elec-
trophoresis and Western blot analyses.
Acyl biotinyl exchange
The ABE assay was carried out as reported 
in Wan et al. (2007) with some modifica-
tions. Briefly, transfected CHO-K1 cells 
grown in 100-mm dishes were washed with 
cold PBS, harvested, lysed, and centrifuged 
as described in the preceding subsection. 
Supernatant was removed, and Triton 
X-100 was added to a final concentration of 
1.7% and incubated with end-over-end ro-
tation at 4°C for 1 h. The proteins were pre-
cipitated with chloroform/methanol (1:4 
vol/vol) and resuspended in SB (4% SDS, 
50 mM Tris HCl, pH 7.4, 5 mM EDTA) with 
10 mM N-ethylmaleimide (NEM) before in-
cubation at 37°C with agitation. LB (50 mM 
Tris HCl, pH 7.4, 5 mM EDTA, 150 mM 
NaCl) with 1 mM NEM, 0.2% Triton X-100, 
protease inhibitor mix (PIM), and phenyl-
methylsulfonyl fluoride (PMSF) was added 
to each sample and incubated overnight at 4°C. NEM from samples 
was removed by three sequential chloroform/methanol precipita-
tions, and they were finally resuspended in SB. The samples were 
divided into two equal portions, with one being incubated with HB 
(1 M hydroxylamine, pH 7.4, 150 mM NaCl, 0.2% Triton X-100, PIM, 
PMSF, 1 mM HPDP-biotin) and the other with TB (LB, 0.2% Triton 
X-100, PIM, PMSF, 1 mM HPDP-biotin) to use as a control at room 
temperature for 1 h. Then the proteins were precipitated with chlo-
roform/methanol to remove unreacted HPDP-biotin and incubated 
with streptavidin agarose beads after resuspension. The samples 
were left 1 h at room temperature with end-over-end rotation. Then 
the elution was carried out in a buffer containing dithiothreitol. All 
samples were processed for Western blot analysis.
Endocytosis of Alexa Fluor 647–conjugated transferrin
This assay was performed as described in Iglesias-Bartolome et al. 
(2006).
Confocal microscopy and image acquisition
Confocal images were collected using an Olympus FluoView 
FV1000 confocal microscope (Olympus Latin America, Miami, FL) 
equipped with a multiline argon laser (458, 488, and 514 nm) and 
two helium–neon lasers (543 and 633 nm, respectively). CFP was 
detected by using laser excitation at 458 nm, a 458/514-nm ex-
citation dichroic mirror, and a 470- to 500-nm band-pass emis-
sion filter. YFP was acquired by using laser excitation at 514 nm, 
a 458/514-nm excitation dichroic mirror, and a 530/570-nm 
band-pass emission filter. Cherry protein was acquired with a la-
ser excitation at 543 nm, a 458/543/633-nm excitation dichroic 
mirror, and a 560-nm long-pass emission filter. Alexa Fluor 647 
was acquired with a laser excitation at 633 nm, a 488/543/633-
nm excitation dichroic mirror, and a 650-nm long-pass emission 
filter. For CFP/YFP/Cherry acquisition, images were sequentially 
acquired in line mode. This minimizes the bleedthrough between 
10% fetal bovine serum (FBS) and antibiotics (100 µg/ml penicillin 
and 100 µg/ml streptomycin). Cells grown on Petri dishes were used 
for both live-cell imaging and Western blot experiments. These cells 
were transfected with 0.2–1 µg/35-mm dish of the indicated plasmid 
using cationic liposomes (Lipofectamine; Invitrogen) or polyethyl-
enimine linear (Polysciences, Warrington, PA). At 24 h after cell 
transfection, cells were processed for Western blot experiments or 
plated onto Lab-Tek chambered coverglasses (Thermo Scientific 
Nunc), incubated for 24 h, and then used in live-cell imaging.
Subcellular fractionation and Triton X-114 partition assay
Subcellular fractionation, the Triton X-114 partition assay, electropho-
resis, and Western blotting were performed as described (Crespo 
et al., 2002; Gomez and Daniotti, 2005, 2007; Trenchi et al., 2009) 
with some modifications. Cells grown onto 60-mm dishes were 
washed with cold phosphate-buffered saline (PBS; 140 mM NaCl, 
8.4 mM Na2HPO4, 1.6 mM NaH2PO4, pH 7.5) and harvested by 
scraping in PBS containing protease inhibitors. Extracts were centri-
fuged at 4°C for 5 min at 13,000 × g and resuspended in 400 µl of 5 
mM Tris-HCl (pH 7.0) in the presence of protease inhibitors. Pellets 
were dispersed by repetitive pipetting and vortexing. After 30 min 
of incubation, pellets were passed 60 times through a 25-gauge 
needle. Nuclear fractions and unbroken cells were removed by cen-
trifuging twice at 4°C for 5 min at 600 × g. Supernatants were then 
ultracentrifuged at 4°C for 1 h at 400,000 × g using a TLA 100.3 ro-
tor (Beckman Coulter). The supernatant (S1 fraction) was removed, 
and the pellet (P1 fraction) was resuspended in 400 µl of 5 mM Tris-
HCl (pH 7.0). Both fractions were further ultracentrifuged at 400,000 
× g, the supernatant of S1 fraction was removed (S fraction), and the 
pellet of P1 fraction was resuspended in 400 µl of buffer (P fraction). 
A 100-µl amount of 5% (vol/vol) TX-114 was added to the S and P 
fractions and incubated at 4°C for 1 h. Then samples were incu-
bated at 37°C for 3 min and centrifuged at 13,000 × g. The aqueous 
upper phase (A) and the detergent-enriched lower phase (D) were 
FIGURE 5: Subcellular trafficking model for acylated versions of H-Ras. The proposed model 
was designed taking into consideration information from the present and previous studies from 
different laboratories. H-Ras proteins are first modified in the cytosol with a farnesyl anchor to 
the cysteine 186 in the CAAX motif. After association with the cytosolic surface of the 
endoplasmic reticulum (ER), H-Ras arrives at the Golgi complex, where specific PAT S-acylates 
the cysteines 181 and 184. After dual acylation at the Golgi complex, H-Ras is included into the 
vesicular carriers directed to the plasma membrane (PM). At the cell surface, H-Ras is 
endocytosed, transported to recycling endosomes (RE), and recycled back to plasma 
membrane. A fraction of H-Ras could eventually be deacylated by APTs, returning by 
nonvesicular transport (Diffusion) to the Golgi complex and/or endoplasmic reticulum, where it 
is again acylated. H-Ras bearing only an acyl group at cysteine 184 (H-Ras(C181S)) or at cysteine 
181 (H-Ras(C184S)) is mainly associated to the Golgi complex or the Golgi and plasma 
membrane, respectively. The endomembrane pools of monoacylated H-Ras are highly dynamic, 
connected, and exchangeable by vesicular transport and/or diffusion after APT deacylation. 
Consequently modulation of thioesterase activities is relevant to determine the mechanisms 
involved in the intracellular trafficking of acylated isoforms of Ras. Nonacylated and farnesylated 
H-Ras(C181,184S) was found at the Golgi complex in reversible connection with membranes of 
the endoplasmic reticulum.
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PBS and fixed with 1% paraformaldehyde, and these fixed cells 
were washed with PBS and rinsed with Milli-Q water. Coverslips 
were visualized using an Olympus FV300 confocal laser scanning 
microscope. A Plan Apochromat 60×/1.42 NA oil immersion objec-
tive lens was used with digitally zoomed 3×, 512 × 512 image resolu-
tion. The ECFP (donor) and EYFP (acceptor) chimeric proteins were 
excited with an argon laser at 458 and 515 nm, respectively, and the 
emission channel was 465–495 nm for the donor and 530–560 nm 
for the acceptor. As a positive control, cells transfected with a chi-
meric CFP fused to YFP was used. Sensitized emission measure-
ment was chosen, with images processed using the PFRET module 
for the FV10-ASW software of the FV1000 microscope.
FRAP and FLIP experiments
FRAP and FLIP experiments were performed using an Olympus 
FluoView FV1000 confocal microscope with a 63× UPlanApo oil im-
mersion/1.42 NA (Olympus) objective. For all of these experiments, 
the pinhole was fully opened in order to minimize changes in fluo-
rescence detection due to Z-drift occurring during time-lapse imag-
ing. For the FRAP experiments, photobleaching was performed us-
ing 50× digital zoom, 50 scans of a 200 pixel × 200 pixel bleaching 
ROI (1024 pixel × 1024 pixel resolution), 8 µs/pixel, direct scan, 
100% transmission of both 458- and 488-nm laser lines (30 mW), 
and a 63× UPlanApo oil immersion/1.42 NA objective. Under these 
conditions, YFP fluorescence after bleaching was <10% of its initial 
value. Prebleaching and postbleaching images (3 and 90 images, 
respectively) were obtained every 10 s from a 512 pixel × 512 pixel 
resolution using the same objective, with these images acquired 
sequentially in each channel (YFP and Cherry). For FLIP experi-
ments, bleaching of the ROI and full image acquisition was per-
formed every 2 min and obtained using the same acquisition pa-
rameters described for prebleaching and postbleaching images in 
FRAP experiments.
Photoactivation experiments
CHO-K1 cells were cotransfected with H-Ras(C181S) or H-
Ras(C184S) fused to PA-GFP (Patterson and Lippincott-Schwartz, 
2004) and Golgi marker GalNAc-T-Cherry or ST3GalII-Cherry 
(Ruggiero et al., 2015) and analyzed by live-cell imaging microscopy. 
The experiments were performed at 37°C using a live-cell chamber, 
with temperature and CO2 (5% air mix) maintained using a controller 
device (Tokai Hit) on the Olympus FluoView FV1000 confocal micro-
scope, which had a 63×/1.42 NA objective and confocal aperture 
set at 370 µm (optical slice, 2.3 µm). In the photoactivation of the 
Golgi experiments, the area to be photoactivated was selected by 
analyzing the fluorescence of the Golgi markers in the red channel. 
This ROI was then irradiated at 405 nm with laser intensity set at 
1–10% for 5 s. Postactivation images were taken with 488- and 543-
nm lasers to acquire green and cherry fluorescence, respectively, 
every 15 s over 20 min. For the endoplasmic reticulum photoactiva-
tion experiments, a small region far from the Golgi signal was se-
lected and irradiated with 405-nm laser intensity set at 1% for 5 s. 
Images postactivation were taken every 15 s for 90 s. Then the 
process was repeated seven times. Photobleaching control experi-
ments were performed using PA-GFP empty vector with the same 
acquisition conditions as described.
Tannic acid treatment
Tannic acid treatment was performed as described (Trenchi et al., 
2009), with some modifications. Briefly, transfected cells grown on 
Lab-Tek chambered coverglass were incubated at 37°C with 1% tan-
nic acid (MP Biomedicals) in PBS (pH 7) for 10 min. Then these cells 
channels mainly due to overlapping emission spectra of these 
fluorochromes.
Live-cell experiments were performed at 37°C (temperature and 
CO2 controller; Tokai Hit, Japan) on an Olympus FluoView FV1000 
confocal microscope.
For subcellular distribution analyses and colocalization of H-Ras 
and its acylation mutants with organelle markers, live-cell experi-
ments were performed at 37°C using a 63×/1.42 numerical aper-
ture (NA) Plan Apo objective oil immersion (Olympus, Japan). 
Images were taken using a 3× digital zoom and an appropriated 
pinhole to obtain 1 Airy unit for the fluorochrome of shortest wave-
length excitation/emission properties (optical slice, 0.8 µm). 
Images of different cells for each dish were taken over a period no 
longer than 30 min. Images are representative of at least three 
independent experiments.
For deacylation measurements, cells coexpressing H-Ras–YFP 
or its acylation mutants and N27GalNAcT-Cherry or H-Ras–YFP, 
N27GalNAcT-Cherry, and APT1/2-CFP were treated with cyclohexi-
mide 1 h before start of the experiments. Live-cell experiments were 
performed at 20°C on the Olympus FluoView FV1000 confocal mi-
croscope to minimize vesicular trafficking (Tomatis et al., 2010) and 
in the presence of 50 µM 2-BP to inhibit PAT but not APT activity 
(Pedro et al., 2013). After selection of cells coexpressing all proteins, 
images were acquired in the YFP and Cherry channels for deacyla-
tion kinetic measurements using a 63×/1.42 NA Plan Apo oil immer-
sion objective (Olympus) with a 3× digital zoom. The image resolu-
tion was 512 × 512 pixels, with a scan speed of 10 ms/pixel, and the 
pinhole was adjusted to obtain an optical slice of 3 µm. Single two-
dimensional images were taken at a frequency of 5 min−1 for 
150 min. These acquisition conditions were optimized to minimize 
bleaching and to sample as rapidly as possible the amount of H-Ras 
at the plasma membrane. All image analysis and the quantification 
method were carried out using ImageJ software as described previ-
ously (Tomatis et al., 2010). For FRAP experiments, cycloheximide 
was added to the cells 1 h before starting the image acquisition. In 
the indicated cases, tannic acid, 2-BP, or palmostatin B was also in-
corporated into the culture medium.
Erk phosphorylation assay
CHO-K1 cells were transfected with H-RasG12V, H-RasG12V(C181S), 
or H-RasG12V(C184S) or were not transfected as a control, and they 
incubated overnight in DMEM with 0.5% FBS. Then the cells were 
left in serum-free DMEM for 3 h at 37°C, and the control cells were 
stimulated with 10% FBS in DMEM for 15 min. The samples were 
processed for Western blot analysis as described earlier.
2-BP treatment
A stock solution of 0.5 M 2-BP (Fluka) was prepared in dimethyl 
sulfoxide (DMSO). To analyze the effect of 2-BP on the steady-state 
subcellular distribution and membrane-binding properties of H-Ras 
and its acylation mutants by live-cell imaging experiments, 60 µg/ml 
cycloheximide was incorporated into the culture medium during 
transfection. Then, 5 h after transfection, 10% FBS was added to the 
medium, and 3 h later, 50 µM 2-BP was also incorporated. After 
30 min of 2-BP treatment, the cycloheximide was removed. Finally, 
after 8 h of cycloheximide withdrawal, cells were used in live-cell 
imaging.
FRET experiments and analysis
CHO-K1 cells were seeded onto 35-mm dishes containing a cover-
slip and grown to 70–80% confluence at the time of transfection, 
which was performed as indicated. Then cells were washed with 
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